Skip to content

Oral Complications After Haematopoietic Stem Cell Transplantation: a Retrospective Study

Oral Complications After Haematopoietic Stem Cell Transplantation: a Retrospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05595070
Acronym
RadboudStem
Enrollment
200
Registered
2022-10-26
Start date
2022-04-01
Completion date
2023-12-31
Last updated
2022-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Complication, Stem Cell Transplant Complications

Brief summary

Haematopoietic stem cell transplantation (HSCT) is a potentially lifesaving treatment option for various diseases. It involves infusion of stem cells after a conditioning regimen of chemotherapy with or without total body irradiation. There is a concern that HSCT and accompanying treatments may increase the risk for oral complications. Nevertheless, longitudinal studies measuring oral health before and after HSCT are scarce. Hence, we formulated the following research question: In adult HSCT recipients, do oral health parameters change from baseline (pre-HSCT) to 3 - 24 months post-HSCT, and is the type of conditioning regimen associated with this change in oral health parameters? To answer this research question, we will use data from the electronic health records of the Radboudumc (Epic and Dentium). We will include at least seventy-five adult patients who are examined both before and after HSCT at the department of Dentistry (Radboudumc) as part of an oral care program. The following oral health parameters were assessed: status praesens, pocket probing depth, bleeding on probing, periodontal epithelial surface area, periodontal inflamed surface area, xerostomia, unstimulated and stimulated salivary flow rate and pH, cariesactivity, oral chronic Graft-versus-Host Disease and dental treatments. Patients were subjected to different regimens in preparation for HSCT, namely myeloablative, reduced intensity or non-myeloablative conditioning. To estimate the association between conditioning regimen and the change in oral health parameters, we will use mixed effects models with random effects, adjusted for potential confounders. Results will be reported as regression coefficients with corresponding 95% confidence intervals.

Interventions

PROCEDUREHaematopoietic stem cell transplantation

Haematopoietic stem cell transplantation (HSCT) is widely used in the treatment of malignant and non-malignant conditions to reconstitute the immune system secondary to cytotoxic conditioning regimens. These regimens, consisting of chemotherapy with or without total body irradiation, cause severe immunosuppression prior to, during and after HSCT. Immune reconstitution takes place by infusion of stem cells either harvested from the patient (autologous HSCT) or from a donor (allogeneic HSCT).

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Allogeneic HSCT between 2013 and 2021 at Radboudumc * Oral focal screening before HSCT, and at least one oral examination after HSCT performed at Department of Dentistry, Radboudumc * Informed consent

Exclusion criteria

* Not meeting the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Number of teethChange from baseline (pre-HSCT) up to 24 months after HSCTNumber of teeth (range 0 - 32)
Number of restorationsChange from baseline (pre-HSCT) up to 24 months after HSCTTotal number of restored tooth surfaces
Pocket probing depthChange from baseline (pre-HSCT) up to 24 months after HSCTPocket probing depth at 6 sites per tooth in millimetres
Bleeding on probingChange from baseline (pre-HSCT) up to 24 months after HSCTProfound bleeding on probing at 6 sites per tooth as yes or no
Unstimulated and chewing stimulated salivary flow rateChange from baseline (pre-HSCT) up to 24 months after HSCTWhole mouth saliva, measured in mL/min
Unstimulated and chewing stimulated salivary pHChange from baseline (pre-HSCT) up to 24 months after HSCTWhole mouth saliva, measured with pH strips

Secondary

MeasureTime frameDescription
Periodontal careBetween baseline (pre-HSCT) and up to 24 months after HSCTNumber of participants per type of periodontal care, categorised in sub- and supragingival cleaning, subgingival cleaning, no cleaning
Periodontal Epithelial Surface AreaChange from baseline (pre-HSCT) up to 24 months after HSCTThe root surface area in square millimetres affected by attachment loss
Preventive measuresBetween baseline (pre-HSCT) and up to 24 months after HSCTNumber of participants per type of preventive measure as fluoride varnish and oral hygiene instructions
Periodontal Inflamed Surface AreaChange from baseline (pre-HSCT) up to 24 months after HSCTThe root surface area in square millimetres affected by attachment loss and inflamed periodontal tissue
XerostomiaChange from baseline (pre-HSCT) up to 24 months after HSCTSubjective oral dryness measured by Xerostomia Inventory questionnaire
CariesactivityUp to 24 months after HSCTLikelihood for development of new caries lesions based on notes recorded by the dentist
Oral chronic Graft-versus-Host DiseaseUp to 24 months after HSCTAssessed with National Institute of Health Oral Mucosal Score (range 0 - 15), higher score means more severe oral manifestations of oral chronic Graft-versus-Host Disease
ExtractionsBetween baseline (pre-HSCT) and up to 24 months after HSCTTotal number of removed teeth (range 0 - 32)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026